PT - JOURNAL ARTICLE AU - Zhou, Quan AU - Zhu, Danping AU - Yan, Huacheng AU - Quan, Jingwen AU - Kuang, Zhenzhan AU - Zhang, Weiyun AU - Huang, Ling AU - Lei, Ting AU - Liu, Jiahui AU - Xiao, Bin AU - Luo, Aiwu AU - Sun, Zhaohui AU - Li, Linhai TI - A preliminary study on analytical performance of serological assay for SARS-CoV-2 IgM/IgG and application in clinical practice AID - 10.1101/2020.05.05.20092551 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.05.20092551 4099 - http://medrxiv.org/content/early/2020/05/09/2020.05.05.20092551.short 4100 - http://medrxiv.org/content/early/2020/05/09/2020.05.05.20092551.full AB - Objective To investigate the performance of serological test and dynamics of serum antibody with the progress of SARS-CoV-2 infections.Methods A total of 419 patients were enrolled including 19 confirmed cases and 400 patients from fever clinics. Their serial serum samples collected during the hospitalization were menstruated for IgM and IgG against SARS-CoV-2 using gold immunochromatographic assay and chemiluminescence immunoassay. We investigated whether thermal inactivation could affect the results of antibody detection. The dynamics of antibodies with the disease progress and false positive factors for antibody testing were also analyzed.Results The positive rate of IgG detection was 91.67% and 83.33% using two CLIA, respectively. However, the IgM positive rate was dramatically declined might due to the lack of blood samples at early stages of the disease. The chemiluminescence immunoassay had a favorable but narrow linear range. Our work showed increased IgG values in serums from virus-negative patients and four negative samples were IgG weak-positive after thermal incubation. Our data showed the specificity of viral N+S proteins was higher than single antigen. Unlike generally thought that IgM appeared earlier than IgG, there is no certain chronological order of IgM and IgG seroconversion in COVID-19 patients. It was difficult to detect antibodies in asymptomatic patients suggesting that their low viral loads were not enough to cause immune response. Analysis of common interferent in three IgG false-positive patients, such as rheumatoid factor, proved that false positives were not caused by these interfering substances and antigenic cross-reaction.Conclusions Viral serological test is an effective means for SARS-CoV-2 infect detection using both chemiluminescence immunoassay and gold immunochromatographic assay. Chemiluminescence immunoassay against multi-antigens has obvious advantages but still need improve in reducing false positives.Competing Interest StatementThe authors have declared no competing interest.Funding StatementSupported by National Natural Science Foundation of China (31901035); Science and Technology Program of Guangzhou(201903010060); The Military Logistics Research Project(CWH17C018)and Military Healthcare Special Project(18BJZ14)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used during the study are available from the corresponding author by request.